Voon Pei Jye , MD (UNIMAS), MRCP (UK), MMED (NUS)

Dr. Voon’s Story

Dr. Voon is an active investigator for numerous cancer trials encompassing early phase through to late phase studies. He has keen interest in oncology development therapeutic, health related quality of life and health care delivery as well as cancer genetic and pharmacogenomic. Dr Voon has published in various peer reviewed journals. He is a recipient for Hold’em for Life Oncology Fellowship Award, University of Toronto and he has won the Scholar Training Award from AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021.

Research Interest

Oncology development therapeutic, health related quality of life and health care delivery, cancer genetic and pharmacogenomic.

Department

Department of Radiotherapy, Oncology and Palliative Care

Professional Experience

present	Head and Medical Oncology, Sarawak General Hospital
2021	Clinical Research Fellowship, Early Drug Development Program, Princess Margaret Cancer Centre, University of Toronto, Canada
2012	Advanced specialist training in Medical Oncology from National University Hospital Singapore
2007	MRCP (UK) and Master of Medicine (Internal Medicine, National University of Singapore)
2001	MD (Universiti Malaysia Sarawak)

 

Specialized organ

Thoracic, Breast, Gastrointestinal

研究実績

Efficacy and safety of ceritinib 450 mg/d with food and 750 mg/d in fasted state in treatment-naïve patients with ALK+ non-small cell lung cancer: Results from the ASCEND-8 Asian subgroup analysis. Cancer Res Treat. 2022 Mar 25.

Byoung Chul Cho, Pei Jye Voon, et al.

• 論文

Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction. J Exp Clin Cancer Res. 2022 Feb 7;41(1):51.

Pei Jye Voon, et al.

• 論文

Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial.

Pei Jye Voon, et al.

• 論文

Exploration of Patient-Related Barriers to Effective Cancer Pain Management in a Diverse Multicultural Developing Country. J Pain Symptom Manage. 2020 Nov 14:S0885-3924(20)30876-9.

Kiu DKL, Lee ZFD, Pei Jye Voon

• 論文

HRQOL Assessment for Solid Tumor Patients on Immuno-Oncology Therapies. Cancer. 2021 Mar 4

Pei Jye Voon, David Cella, Aaron R Hansen

• 論文

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

K Park, J Vansteenkiste, K H Lee, G Pentheroudakis, C Zhou, K Prabhash, T Seto, P J Voon, D S W Tan, J C H Yang, J Wang, K Govind Babu, Y Nakayama, A Alip, K L M Chua, J C-H Cheng, S Senan, Y C Ahn, T Yoshino, J-Y Douillard, et al.

• 論文

Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017

Marniza Saad, Adlinda Alip, Jasmine Lim, Matin Mellor Abdullah, Flora Li Tze Chong, Chong Beng Chua, Fuad Ismail, Rachael Kit-Tsan Khong, Chun Sen Lim, Chit Sin Loh, Rohan Malek, Khairul Asri Mohd Ghani, Ibtisam Md Noor, Noor Ashani Md Yusoff, Noor Azam Nasuha, Azad Razack, Hwoei Fen Soo Hoo, Murali Sundram, Pei Jye Voon, Teng Aik Ong

• 論文

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment in patients with EGFRm advanced NSCLC: FLAURA Asian subset. Journal of Thoracic Oncology. Thorac Oncol. 2019 Jan;14(1):99-106.

Young Chul Cho, Pei Jye Voon, et al.

• 論文

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer. N Engl J Med. 2018 Jan 11;378(2):113-125.

Jean-Charles Soria, Pei Jye Voon, et al.

• 論文

EGFR Exon 20 Insertion A763-Y764insFQEA and response to Erlotinib. Molecular Cancer Therapeutics. Volume 12, Issue 11, pp. 2614-2615.

Pei Jye Voon, et al.

• 論文

Correlation of Aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients. Br J Clin Pharmacol. 2013 Jun;75(6): 1497-505. doi.org/10.1111/bcp.12021

Pei Jye Voon, et al.

• 論文

The role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of advanced stage non-small cell lung cancer. J Thorac Dis 2010. J Thorac Dis. 2010 Sep; 2(3): 144–153.

Pei Jye Voon, et al.

• 論文